# Long-term effectiveness of inpatient and day hospital treatment in departments of psychosomatic medicine and psychotherapy in Germany

**Authors:** Henrik Kessler, Stephan Doering, Aram Kehyayan, Magdalena Pape, Tobias Hofmann, Matthias Rose, Katrin Imbierowicz, Franziska Geiser, Ilona Croy, Kerstin Weidner, Jörg Rademacher, Silke Michalek, Eva Morawa, Yesim Erim, Christoph Jansen, Martin Teufel, Stanislav Heinzmann, Claas Lahmann, Eva Milena Johanne Peters, Johannes Kruse, Dirk von Boetticher, Christoph Herrmann-Lingen, Mariel Nöhre, Martina de Zwaan, Ulrike Dinger, Hans-Christoph Friederich, Alexander Niecke, Christian Albus, Rüdiger Zwerenz, Manfred Beutel, Casper Roenneberg, Peter Henningsen, Barbara Stein, Christiane Waller, Karsten Hake, Carsten Spitzer, Andreas Stengel, Stephan Zipfel, Katja Weimer, Harald Gündel, Stephan Herpertz

PMC · DOI: 10.3389/fpsyt.2025.1531504 · Frontiers in Psychiatry · 2025-10-29

## TL;DR

This study shows that inpatient and day hospital treatment in Germany leads to lasting improvements in mental health symptoms over a year.

## Contribution

The study provides naturalistic evidence of sustained treatment effectiveness over a 12-month follow-up period.

## Key findings

- Significant improvements in symptoms were maintained 12 months after treatment discharge.
- Large effect sizes were observed across all symptom domains, including anxiety, depression, and eating disorders.
- The results confirm the long-term effectiveness of psychosomatic inpatient and day hospital treatment in Germany.

## Abstract

There is a lack of reliable data concerning the long-term effectiveness of psychosomatic inpatient and day hospital treatment in a naturalistic setting. The Multicenter Effectiveness Study of Inpatient and Day Hospital Treatment in Departments of Psychosomatic Medicine and Psychotherapy in Germany aims to provide such data. The study itself and effectiveness from admission to discharge have already been reported in this journal (Doering et al., 2023). This brief report adds 12-month follow-up data.

The relevant outcome variables concerning somatoform, trauma-related, eating and personality disorders, as well as anxiety and depressive disorders were assessed by means of questionnaires on admission (T0), at discharge (T1) and after 12 months (T2). In order to make targeted statements about effectiveness regarding only clinically relevant symptoms, each symptom domain was stratified by severity at admission.

From a total of 2,094 patients at admission, 60.6% still provided data at T2. Overall, the changes achieved at discharge (T1) already reported in Doering (2023) remained stable over the 12-month follow-up period (T2). There were hence significant improvements from T0 to T2 across all symptom domains with large effect sizes ranging from d=1.0 to 3.4.

The already reported effectiveness of inpatient and day hospital treatment in German university departments of Psychosomatic Medicine and Psychotherapy in a naturalistic setting is further strengthened by providing evidence for sustained treatment effects over the 12-month follow-up period. Importantly, the entire spectrum of disorders investigated showed this pattern.

https://drks.de/search/de/trial/DRKS00016412 RKS00016412, identifier DRKS00016412.

## Full-text entities

- **Diseases:** depressive disorders (MESH:D003866), eating and personality disorders (MESH:D001068), anxiety (MESH:D001007), trauma (MESH:D014947)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12605911/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12605911/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC12605911/full.md

---
Source: https://tomesphere.com/paper/PMC12605911